Write in a clean editor, then format for Diabetic Medicine in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Diabetic Medicine is a peer-reviewed journal published by Wiley, covering Diabetes Management and Research, Diabetes Management and Education, Diabetes, Cardiovascular Risks, and Lipoproteins.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Diabetic Medicine 12 (3): 45–58.
Formats any DOI in Diabetic Medicine style. No sign-up. |
| Publishes research in | Diabetes Management and Research Diabetes Management and Education Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes and associated disorders Diabetes Treatment and Management |
| ISSN | 0742-3071 |
| Citation impact (2-yr) | 2.26 |
| h-index | 210 |
| i10-index | 6,396 |
| Total citations | 396,590 |
| Article processing charge | $4,640 |
| Top institutions publishing here | Diabetes UK |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The classification of diabetes mellitus and the tests used for its diagnosis were brought into order by the National Diabetes Data Group of the USA and the second World Health Organization Expert Committee on Diabetes Mellitus in 1979 and 1980. Apart from minor modifications by WHO in 1985, little has been changed since that time.…
AIMS: To establish a unified working diagnostic tool for the metabolic syndrome (MetS) that is convenient to use in clinical practice and that can be used world-wide so that data from different countries can be compared. An additional aim was to highlight areas where more research into the MetS is needed. PARTICIPANTS: The International Diabetes…
Prevention and control programmes are needed to stem the rising epidemic of diabetes and its complications. However, these will not occur unless governments and public health planners are aware of the potential problem. Using published prevalence rates for NIDDM in different populations, and the current and projected age distributions, worldwide prevalence of NIDDM was estimated…
A workshop was convened by the International Diabetes Federation to review the latest information relating to the risks associated with impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG) for future diabetes and cardiovascular disease (CVD). The workshop sought to address three questions: (i) are the current definitions of IGT and IFG appropriate; (ii) are…
